<DOC>
	<DOCNO>NCT00064376</DOCNO>
	<brief_summary>RATIONALE : Paricalcitol form vitamin D may help myelodysplastic cell develop normal bone marrow cell . PURPOSE : Phase II trial study effectiveness paricalcitol treat patient myelodysplastic syndrome .</brief_summary>
	<brief_title>Paricalcitol Treating Patients With Myelodysplastic Syndrome</brief_title>
	<detailed_description>OBJECTIVES : - Determine clinical effect paricalcitol patient myelodysplastic syndrome . - Determine whether drug improve RBC , WBC , platelet count patient . - Determine whether drug decrease risk development leukemia without cause undue toxicity patient . OUTLINE : Patients receive oral paricalcitol daily 4 month absence disease progression unacceptable toxicity . Patients follow 1 month . PROJECTED ACCRUAL : A total 20 patient accrue study within 8 month .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Clinical diagnosis myelodysplastic syndrome accord modify FAB classification Confirmed bone marrow aspiration show blast promyelocyte count great 30 % bone marrow differential Patients refractory anemia ring sideroblast eligible provide response 3week course prior highdose pyridoxine PATIENT CHARACTERISTICS : Age 25 100 Performance status Karnofsky 60100 % Life expectancy At least 12 week Hematopoietic See Disease Characteristics Hepatic Bilirubin le 2.0 mg/dL Renal Creatinine le 2.5 mg/dL Calcium normal Other Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No prior sensitivity paricalcitol component formulation No prior cholecalciferol toxicity No concurrent acute illness PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy More 5 week since prior chemotherapy Endocrine therapy Not specify Radiotherapy More 5 week since prior radiotherapy Surgery Prior recent surgery allow , fully recover Other More 5 week since prior megadose vitamin No concurrent cholecalciferol , phosphate , calcium , cholestyramine No concurrent digoxin</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2004</verification_date>
	<keyword>de novo myelodysplastic syndrome</keyword>
	<keyword>previously treat myelodysplastic syndrome</keyword>
	<keyword>secondary myelodysplastic syndrome</keyword>
	<keyword>refractory anemia excess blast transformation</keyword>
	<keyword>refractory anemia excess blast</keyword>
	<keyword>refractory anemia ring sideroblast</keyword>
	<keyword>refractory anemia</keyword>
	<keyword>chronic myelomonocytic leukemia</keyword>
</DOC>